Literature DB >> 16602485

August Weismann's theory of the germ-plasm and the problem of unconceived alternatives.

P Kyle Stanford1.   

Abstract

I have argued elsewhere that scientific realism is most significantly challenged neither by traditional arguments from underdetermination of theories by the evidence, nor by the traditional pessimistic induction, but by a rather different historical pattern: our repeated failure to conceive of alternatives to extant scientific theories, even when those alternatives were both (1) well-confirmed by the evidence available at the time and (2) sufficiently scientifically serious as to be later embraced by actual scientific communities. Here I use August Weismann's defense of his influential germ-plasm theory of inheritance to support my claim that this pattern characterizes the history of theoretical scientific investigation generally. Weismann believed that the germ-plasm must become disintegrated into its constituent elements over the course of development, I argue, only because he failed to conceive of any possible alternative mechanism of ontogenetic differentiation. This and other features of the germ-plasm theory, I suggest, reflect a still more fundamental failure to imagine that the germ-plasm might be a productive rather than expendable resource for the cell. Weismann's case provides impressive support for the problem of unconceived alternatives while rendering its challenge to scientific realism deeper and sharper in a number of important ways.

Entities:  

Mesh:

Year:  2005        PMID: 16602485

Source DB:  PubMed          Journal:  Hist Philos Life Sci        ISSN: 0391-9714            Impact factor:   1.205


  2 in total

1.  Weismann versus morgan revisited: clashing interpretations on animal regeneration.

Authors:  Maurizio Esposito
Journal:  J Hist Biol       Date:  2013       Impact factor: 1.326

2.  An ESR Framework for the Study of Consciousness.

Authors:  Diana Stanciu
Journal:  Entropy (Basel)       Date:  2021-01-11       Impact factor: 2.524

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.